Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
16 Nov 2020 - 17 Nov 2020

Bryan Garnier European Healthcare Conference 2020 – virtual event

13 Nov 2020 - 15 Nov 2020

American Academy of Ophthalmology 2020 – Virtual

03 November 2020

GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency

06 Nov 2020

Eyecelerator 2020 – Virtual Conference

02 Nov 2020 - 05 Nov 2020

World Orphan Drug Congress Europe 2020 – Live Digital

22 October 2020

GenSight Biologics successfully raises €25 million in an oversubscribed private placement with US and European institutional investors

21 October 2020

GenSight Biologics launches a capital increase of approximately €25 million by means of an accelerated bookbuilding process

26 Oct 2020 - 29 Oct 2020

BioEurope – Digital

26 Oct 2020 - 28 Oct 2020

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

15 October 2020

GenSight Biologics Reports Cash Position as of September 30, 2020 and Provides Operational Update

  • View previous 9 articles
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page